MetS‐Z: A gender‐ and age‐specific scoring system for predicting type 2 diabetes

ABSTRACT Aims Current metabolic syndrome (mets) criteria often lack consideration for age and gender differences. This study introduces the mets‐Z score, a novel tool designed to enhance mets assessment and improve long‐term outcome predictions. Materials and Methods The mets‐Z score was developed u...

Full description

Saved in:
Bibliographic Details
Main Authors: Paul Wei‐Che Hsu, Yi‐Rong Chen, Wayne Huey‐Herng Sheu
Format: Article
Language:English
Published: Wiley 2025-05-01
Series:Journal of Diabetes Investigation
Subjects:
Online Access:https://doi.org/10.1111/jdi.70004
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850187787831083008
author Paul Wei‐Che Hsu
Yi‐Rong Chen
Wayne Huey‐Herng Sheu
author_facet Paul Wei‐Che Hsu
Yi‐Rong Chen
Wayne Huey‐Herng Sheu
author_sort Paul Wei‐Che Hsu
collection DOAJ
description ABSTRACT Aims Current metabolic syndrome (mets) criteria often lack consideration for age and gender differences. This study introduces the mets‐Z score, a novel tool designed to enhance mets assessment and improve long‐term outcome predictions. Materials and Methods The mets‐Z score was developed using principal component analysis (PCA) to weight five mets indicators—waist circumference, blood glucose, blood pressure, high‐density lipoprotein (HDL) cholesterol, and triglycerides—by gender and age. Data from 188,739 Taiwan Biobank participants, stratified by gender and age groups (20–39, 40–54, 55–64, 65+ years), were analyzed. Predictive performance for type 2 diabetes mellitus onset was assessed over a 4‐ to 5‐year follow‐up. Results The mets‐Z score achieved superior accuracy in predicting type 2 diabetes mellitus onset, with an AUC of 0.76 in men and 0.80 in women, significantly outperforming conventional indices (P < 0.0001). Conclusions By integrating age‐ and gender‐specific variations, the mets‐Z score provides a more personalized and precise tool for assessing metabolic and diabetes risk, surpassing existing methods. The tool is available for public use at http://bioinfolab.nhri.edu.tw/metsz/, supporting broader applications in precision medicine.
format Article
id doaj-art-4f0fa85e539b48d3b9249d07bce0ccaa
institution OA Journals
issn 2040-1116
2040-1124
language English
publishDate 2025-05-01
publisher Wiley
record_format Article
series Journal of Diabetes Investigation
spelling doaj-art-4f0fa85e539b48d3b9249d07bce0ccaa2025-08-20T02:16:02ZengWileyJournal of Diabetes Investigation2040-11162040-11242025-05-0116590791610.1111/jdi.70004MetS‐Z: A gender‐ and age‐specific scoring system for predicting type 2 diabetesPaul Wei‐Che Hsu0Yi‐Rong Chen1Wayne Huey‐Herng Sheu2Institute of Molecular and Genomic Medicine National Health Research Institutes Zhunan TaiwanInstitute of Molecular and Genomic Medicine National Health Research Institutes Zhunan TaiwanInstitute of Molecular and Genomic Medicine National Health Research Institutes Zhunan TaiwanABSTRACT Aims Current metabolic syndrome (mets) criteria often lack consideration for age and gender differences. This study introduces the mets‐Z score, a novel tool designed to enhance mets assessment and improve long‐term outcome predictions. Materials and Methods The mets‐Z score was developed using principal component analysis (PCA) to weight five mets indicators—waist circumference, blood glucose, blood pressure, high‐density lipoprotein (HDL) cholesterol, and triglycerides—by gender and age. Data from 188,739 Taiwan Biobank participants, stratified by gender and age groups (20–39, 40–54, 55–64, 65+ years), were analyzed. Predictive performance for type 2 diabetes mellitus onset was assessed over a 4‐ to 5‐year follow‐up. Results The mets‐Z score achieved superior accuracy in predicting type 2 diabetes mellitus onset, with an AUC of 0.76 in men and 0.80 in women, significantly outperforming conventional indices (P < 0.0001). Conclusions By integrating age‐ and gender‐specific variations, the mets‐Z score provides a more personalized and precise tool for assessing metabolic and diabetes risk, surpassing existing methods. The tool is available for public use at http://bioinfolab.nhri.edu.tw/metsz/, supporting broader applications in precision medicine.https://doi.org/10.1111/jdi.70004Metabolic syndromePredictionType 2 diabetes mellitus
spellingShingle Paul Wei‐Che Hsu
Yi‐Rong Chen
Wayne Huey‐Herng Sheu
MetS‐Z: A gender‐ and age‐specific scoring system for predicting type 2 diabetes
Journal of Diabetes Investigation
Metabolic syndrome
Prediction
Type 2 diabetes mellitus
title MetS‐Z: A gender‐ and age‐specific scoring system for predicting type 2 diabetes
title_full MetS‐Z: A gender‐ and age‐specific scoring system for predicting type 2 diabetes
title_fullStr MetS‐Z: A gender‐ and age‐specific scoring system for predicting type 2 diabetes
title_full_unstemmed MetS‐Z: A gender‐ and age‐specific scoring system for predicting type 2 diabetes
title_short MetS‐Z: A gender‐ and age‐specific scoring system for predicting type 2 diabetes
title_sort mets z a gender and age specific scoring system for predicting type 2 diabetes
topic Metabolic syndrome
Prediction
Type 2 diabetes mellitus
url https://doi.org/10.1111/jdi.70004
work_keys_str_mv AT paulweichehsu metszagenderandagespecificscoringsystemforpredictingtype2diabetes
AT yirongchen metszagenderandagespecificscoringsystemforpredictingtype2diabetes
AT waynehueyherngsheu metszagenderandagespecificscoringsystemforpredictingtype2diabetes